Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Sung Lee sold 4,935 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total value of $306,710.25. Following the completion of the transaction, the executive vice president directly owned 87,127 […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Fady Ibraham Malik sold 12,033 shares of Cytokinetics stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $747,850.95. Following the completion of the transaction, the executive vice president owned 153,902 shares in the […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert Blum sold 36,601 shares of Cytokinetics stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $62.15, for a total transaction of $2,274,752.15. Following the completion of the sale, the chief executive officer directly owned 430,330 shares […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Andrew Callos sold 1,709 shares of the stock in a transaction on Monday, March 16th. The shares were sold at an average price of $61.03, for a total transaction of $104,300.27. Following the completion of the sale, the executive vice president owned 46,149 shares of the company’s […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Andrew Callos sold 2,582 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $60.72, for a total value of $156,779.04. Following the transaction, the executive vice president directly owned 47,858 shares of the […]